Table 3.
Predictors of 30-, 90-, and 180-day readmissions.
Characteristics | β | p-value | OR | 95% CI |
---|---|---|---|---|
30-day readmission | ||||
No insurance | 1.155 | 0.047 | 3.173 | 1.015, 9.915 |
Alcoholic liver disease | 1.302 | 0.037 | 3.675 | 1.081, 12.491 |
Ascites | 2.019 | 0.006 | 7.529 | 1.780, 31.855 |
MELD score at discharge | 0.191 | < 0.001 | 1.210 | 1.125, 1.302 |
NLR at discharge | 0.058 | 0.044 | 1.060 | 1.002, 1.122 |
90-day readmission | ||||
Age | 0.036 | 0.024 | 1.036 | 1.005, 1.069 |
No insurance | 0.770 | 0.048 | 2.159 | 1.006, 4.633 |
Alcoholic liver disease | 0.821 | 0.035 | 2.274 | 1.061, 4.873 |
Hepatocellular carcinoma | 1.044 | 0.022 | 2.841 | 1.162, 6.945 |
Ascites | 0.772 | 0.036 | 2.164 | 1.051, 4.456 |
MELD score at discharge | 0.165 | < 0.001 | 1.180 | 1.122, 1.240 |
NLR at discharge | 0.066 | 0.008 | 1.068 | 1.017, 1.112 |
180-day readmission | ||||
Age | 0.040 | 0.003 | 1.041 | 1.013, 1.069 |
No insurance | 1.003 | 0.003 | 2.727 | 1.415, 5.256 |
Alcoholic liver disease | 0.932 | 0.006 | 2.539 | 1.311, 4.915 |
Hepatocellular carcinoma | 0.891 | 0.031 | 2.438 | 1.085, 5.476 |
Ascites | 0.701 | 0.022 | 2.016 | 1.105, 3.679 |
MELD score at discharge | 0.141 | < 0.001 | 1.151 | 1.102, 1.203 |
NLR at discharge | 0.077 | 0.002 | 1.080 | 1.030, 1.133 |
MELD, model for end-stage liver disease; NLR, neutrophil-to-lymphocyte ratio.